Founded in 2006, Cerebio is a leading global biomedical research and drug development company, providing transgenic rodent models and advanced CRO solutions. With over 900 employees and multiple R&D centers spanning 40,000 square meters, Cerebio serves researchers in over 100 countries and has supported the publication of over 13,000 peer-reviewed papers, including those in journals such as Cell, Nature, and Science.